Renalytix Market Cap

Renalytix has a market cap or net worth of $32.34 million as of June 23, 2025. Its market cap has decreased by -0.21% in one year.

Market Cap

32.34M

Enterprise Value

30.82M

Revenue

2.89M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.20

Market Cap Chart

Since November 6, 2018, Renalytix's market cap has decreased from 84.47M to 32.34M, a decrease of -61.71%. That is a compound annual growth rate of -13.49%.

Market Cap History

Date	Market Cap	% Change
Jun 20, 2025	32.34M	-27.44%
Dec 31, 2024	44.57M	125.93%
Dec 29, 2023	19.73M	-69.84%
Dec 30, 2022	65.42M	-89.22%
Dec 31, 2021	607.05M	26.62%
Dec 31, 2020	479.42M	67.37%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Elite Pharmaceuticals	792.66M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
American Oncology Network	435.36M
Glass House Brands	393.08M
CytoDyn	387.16M

Market Cap Rankings